Making and evaluating a statistical prediction model for the absolute risk of prostate cancer recurrence

Cancer

Volumn 117, Issue 22, 2011, Pages 5026-5028

  Kattan, Michael W ^a   Gerds, Thomas A ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CAPRA S SCORE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS;

HUMANS; MALE; POSTOPERATIVE PERIOD; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 80555150791     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26174     Document Type: Review

References (11)

1. Cooperberg M, Hilton J, Caroll P,., Kattan MW,. The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer. 2011; 117: 000-000.
2. Chiang CL,. A stochastic study of the life table and its implications. III: the follow-up study with the consideration of competing risks. Biometrics. 1961; 17: 57-78.
3. Gooley TA, Lesienring W, Crowley J, Storer BE,. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18: 695-706. (Pubitemid 29126745)
4. Steyerberg EW, Gerds TA,. Concepts in cancer survival analysis: research questions, data and models. Surg Oncol. 2010; 19: 52-54.
5. Andersen PK, Keiding N,. Research Report. Copenhagen: Department of Biostatistics, University of Copenhagen; 2010.
6. Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007; 177: 540-545. (Pubitemid 46054056)
7. Stephenson AJ, Kattan MW, Eastham JA, et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol. 2006; 24: 3973-3978. (Pubitemid 46630746)
8. Cronin AM, Godoy G, Vickers AJ,. Definition of biochemical recurrence after radical prostatetomy does not substantially impact prognostic factor estimates. J Urol. 2010; 183: 984-989.
9. Gail MH, Pfeiffer RM,. On criteria for evaluating models of absolute risk. Biostatistics. 2005; 6: 227-239. (Pubitemid 41240355)
10. Schumacher M, Graf E, Gerds TA,. How to assess prognostic models for survival data: a case study in oncology. Methods Inf Med. 2003; 42: 564-571. (Pubitemid 38055497)
11. Simon R,. Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol. 2005; 23: 7332-7341. (Pubitemid 46202346)